$2.5m medicine is ‘game-changer’ for infants with genetic disorder – BBC News

by

BBC News published this video item, entitled “$2.5m medicine is ‘game-changer’ for infants with genetic disorder – BBC News” – below is their description.

A baby boy has become one of the first patients to be treated on the UK’s NHS with Zolgensma, the world’s most expensive medicine.

Little Arthur is one of around 40 children are born with the most severe form of Spinal Muscular Atrophy (SMA) every year.

The gene therapy has a list price of about $2.5m and is manufactured by Novartis Gene Therapies.

BBC News YouTube Channel

Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.


About This Source - BBC News

The video item below is a piece of English language content from BBC News. The British Broadcasting Corporation (BBC) is a British public service broadcaster funded by the UK Government, and British license fee payers. Its headquarters are at Broadcasting House in Westminster, London.

Recent from BBC News:

Japan lands on moon but glitch threatens mission | bbc news 1

Japan lands on Moon but glitch threatens mission | BBC News

Category: Energy, News, Renewable Energy

Kneecap: Irish language rappers debut film at Sundance | BBC News

Category: News

Violent crime soars in South Africa with murders at 20-year high | BBC News

Category: News

In This Story: Novartis

Novartis International AG is a Swiss multinational pharmaceutical company based in Basel, Switzerland. It is one of the largest pharmaceutical companies by both market capitalization and sales.

2 Recent Items: Novartis

Novartis CEO explains discusses how AI will impact drug development

Category: Business, Finance, Pharmaceuticals

Novartis CEO on the company’s overall M&A strategy #Shorts

Category: News, Pharmaceuticals

Leave a Comment

We don't require your email address, or your name, for anyone to leave a comment. If you do add an email address, you may be notified if there are replies to your comment - we won't use it for any other purpose. Please make respectful comments, which add value, and avoid personal attacks on others. Links are not allowed in comments - 99% of spam comments, attempt to post links. Please describe where people may find additional information - for example "visit the UN website" or "search Google for..." rather than posting a link. Comments failing to adhere to these guidelines will not be published.